Options: Show MedDRA Preferred Terms, display all 29 labels
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arrhythmia | x | x | x | x | x | x | x | x | ||||||||||||||
| Asthma | x | x | x | x | x | |||||||||||||||||
| Atrial fibrillation and flutter | x | x | x | x | x | |||||||||||||||||
| Drug interaction | x | x | x | x | x | x | ||||||||||||||||
| Hyperkinesia | x | x | x | x | ||||||||||||||||||
| Pulmonary fibrosis | x | x | x | x | ||||||||||||||||||
| Recurrent ventricular fibrillation | x | x | x | x | x | x | x | x | ||||||||||||||
| Respiratory failure | x | x | x | x | ||||||||||||||||||
| Sinoatrial node dysfunction | x | x | x | x | ||||||||||||||||||
| Sudden death | x | x | x | |||||||||||||||||||
| Tachyarrhythmia | x | x | x | x | x | |||||||||||||||||
| Ventricular arrhythmia | x | x | x | x | x | x | x | x | x | x | x | x | ||||||||||
| Ventricular fibrillation | x | x | x | x | x | x | x | x | x | |||||||||||||
| Ventricular tachycardia | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Wolff-Parkinson-White syndrome | x | x | x | x | x | |||||||||||||||||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |